의약품 관련 법령
Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations; Draft Guidance for Industry
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 767 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM610678.pdf | ||
첨부파일 |
Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations; Draft Guidance for Industry
- 이전글 S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
- 다음글 Pre-ion Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry